Vicapsys Life Sciences, Inc. (VICP) stock
VICPOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Jan 10, 2025
$0.40+0.00 (0.00%)
Close on Oct 19, 2026Market cap $13.73MP/E –Yield –
Vicapsys Life Sciences gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
No gross profit figures for Vicapsys Life Sciences
Vicapsys Life Sciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?